is semaglutide compound safe The FDA Warns of the Risks Using Compounded May Entail FDA alerts health care providers,

Californias board of pharmacy has gone the farthest, revoking Empowers permits and then staying the decision and placing Empower on probation for four years starting in 2023

GLP-1 therapy typically produces 1015% body weight loss over 612 months, which translates to an average 1015 mmHg systolic blood pressure reduction in responders

What will happen as more research is done and more drugs are developed is that well transition to even more effective medicines, but I don't think theyll get off medicine

What doctors do know is that GLP-1 medications seem to suppress appetite

Bret: Yeah, and thats a great point, preventing versus treating as you both have alluded to, but I want to circle back to what you said, Gary, that there is a study showing that maybe only 25% of people stay on the drugs at a year